 <h1>Dronedarone Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>More frequently reported side effects include:</b> abdominal pain, allergic dermatitis, diarrhea, eczema, nausea, pruritus, and skin rash.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to dronedarone: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>In patients with symptomatic heart failure and recent decompensation requiring hospitalization or NYHA Class IV heart failure, dronedarone hydrochloride doubles the risk of death. Dronedarone hydrochloride is contraindicated in patients with symptomatic heart failure with recent decompensation requiring hospitalization or NYHA Class IV heart failure. In patients with permanent atrial fibrillation, dronedarone hydrochloride doubles the risk of death, stroke, and hospitalization for heart failure. Dronedarone hydrochloride is contraindicated in patients in atrial fibrillation (AF) who will not or cannot be cardioverted into normal sinus rhythm .</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, dronedarone may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking dronedarone:</p><p>
<i>Less common</i>
</p><ul>
<li>Chest pain or discomfort</li>
<li>lightheadedness, dizziness, or fainting</li>
<li>shortness of breath</li>
<li>slow or irregular heartbeat</li>
<li>unusual tiredness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Abdominal or stomach pain, severe</li>
<li>chills</li>
<li>cough</li>
<li>dark urine</li>
<li>fever</li>
<li>general feeling of discomfort or illness</li>
<li>loss of appetite</li>
<li>nausea or vomiting</li>
<li>thickening of bronchial secretions</li>
<li>unusual tiredness or weakness</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of dronedarone may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Diarrhea</li>
<li>lack or loss of strength</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>blistering, crusting, irritation, itching, or reddening of the skin</li>
<li>cracked, dry, or scaly skin</li>
<li>heartburn</li>
<li>indigestion</li>
<li>itching skin</li>
<li>rash</li>
<li>redness or discoloration of the skin</li>
<li>skin rash, encrusted, scaly, and oozing</li>
<li>skin rash, hives, itching, or redness</li>
<li>stomach discomfort, upset, or pain</li>
<li>swelling</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Change in taste</li>
<li>increased sensitivity of the skin to sunlight</li>
<li>loss of taste</li>
<li>severe sunburn</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to dronedarone: oral tablet</i></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): QT prolongation (28%)</p>
<p><b>Common</b> (1% to 10%): Bradycardia</p>
<p><b>Very rare</b> (less than 0.01%): New or worsening heart failure, atrial flutter with 1:1 atrioventricular conduction<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Hypokalemia and hypomagnesemia with potassium-depleting diuretics, serum creatinine increased 10% or more within 5 days after treatment initiation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, nausea, abdominal pain, vomiting, dyspeptic symptoms</p>
<p><b>Frequency not reported</b>: Dysgeusia, ageusia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rashes (generalized, macular, maculopapular, erythematous), pruritus, eczema, dermatitis, allergic dermatitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Photosensitivity<sup>[Ref]</sup></p><h3>General</h3><p><b>Common</b> (1% to 10%): Asthenia, fatigue<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Liver injury, including acute liver failure requiring transplant, serum hepatic enzymes, serum bilirubin increase</p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Dyspnea, nonproductive cough </p>
<p><b>Postmarketing reports</b>: Interstitial lung disease including pneumonitis and pulmonary fibrosis</p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p><h3>Hematologic</h3><p><b>Postmarketing reports</b>: Vasculitis, including leukocytoclastic vasculitis</p><h3>Immunologic</h3><p><b>Postmarketing reports</b>: Anaphylactic reactions including angioedema</p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Increased serum creatinine<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Multaq (dronedarone)." sanofi-aventis , Bridgewater, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about dronedarone</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>48 Reviews</li>
<li>Drug class: group III antiarrhythmics</li>
<li>FDA Alerts (3)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Dronedarone &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Multaq</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Atrial Fibrillation</li>
<li>Atrial Flutter</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to dronedarone: oral tablet</i></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): QT prolongation (28%)</p><p><b>Common</b> (1% to 10%): Bradycardia</p><p><b>Very rare</b> (less than 0.01%): New or worsening heart failure, atrial flutter with 1:1 atrioventricular conduction<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Hypokalemia and hypomagnesemia with potassium-depleting diuretics, serum creatinine increased 10% or more within 5 days after treatment initiation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, nausea, abdominal pain, vomiting, dyspeptic symptoms</p><p><b>Frequency not reported</b>: Dysgeusia, ageusia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rashes (generalized, macular, maculopapular, erythematous), pruritus, eczema, dermatitis, allergic dermatitis</p><p><b>Uncommon</b> (0.1% to 1%): Photosensitivity<sup>[Ref]</sup></p><h3>General</h3><p><b>Common</b> (1% to 10%): Asthenia, fatigue<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Liver injury, including acute liver failure requiring transplant, serum hepatic enzymes, serum bilirubin increase</p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Dyspnea, nonproductive cough </p><p><b>Postmarketing reports</b>: Interstitial lung disease including pneumonitis and pulmonary fibrosis</p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p><h3>Hematologic</h3><p><b>Postmarketing reports</b>: Vasculitis, including leukocytoclastic vasculitis</p><h3>Immunologic</h3><p><b>Postmarketing reports</b>: Anaphylactic reactions including angioedema</p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Increased serum creatinine<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Multaq (dronedarone)." sanofi-aventis , Bridgewater, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about dronedarone</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>48 Reviews</li>
<li>Drug class: group III antiarrhythmics</li>
<li>FDA Alerts (3)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Dronedarone &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Atrial Fibrillation</li>
<li>Atrial Flutter</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>